PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8223866-2	1993	The low IL-5 production in BALB/c mice persists when either picryl chloride or the unrelated antigen oxazolone are used, when the amount of antigen in vitro is varied and when a secondary response is studied.	Oxazolone	101-110	interleukin 5	Mus musculus	8-12	
21037078-2	2010	We tested the hypothesis that the IL-5 response to helminth infection enhances the severity of oxazolone-induced colitis.	Oxazolone	95-104	interleukin 5	Mus musculus	34-38	
21037078-9	2010	Mice receiving Ad.IL-5 only had no colitis, while oxazolone-induced colitis was more severe in animals cotreated with Ad.IL-5 (Ad.delete + oxazolone was not significantly different from oxazolone only).	Oxazolone	50-59	interleukin 5	Mus musculus	118-125	
9815270-3	1998	Oxazolone colitis is a T helper cell type 2 (Th2)-mediated process since stimulated T cells from lesional tissue produce markedly increased amounts of interleukin (IL)-4 and IL-5; in addition, anti-IL-4 administration leads to a striking amelioration of disease, whereas anti-IL-12 administration either has no effect or exacerbates disease.	Oxazolone	0-9	interleukin 5	Mus musculus	174-178	
31328158-0	2019	The regulatory B cell-mediated peripheral tolerance maintained by mast cell IL-5 suppresses oxazolone-induced contact hypersensitivity.	Oxazolone	92-101	interleukin 5	Mus musculus	76-80	
23161496-5	2014	Oxazolone-challenged L2-IL5 mice developed dose-dependent pan-oesophageal eosinophilia, including eosinophil microabscess formation and degranulation as well as basal cell hyperplasia.	Oxazolone	0-9	interleukin 5	Mus musculus	24-27